SPP1 and neurodegenerative disease: The presence of OPN in cerebrospinal fluid (CSF) and its dynamic regulation during disease progression raises the possibility that bone-derived OPN may serve as a biomarker of brain inflammation and as a modifiable target in conditions like traumatic brain injury and neurodegenerative disease [58].